Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Devenport

Showing results (181-190 of 197) with videos related to

Pageof 20
Sort By:
Nature Communications|June 13, 2022
A long-acting interleukin-7, rhIL-7-hyFc, enhances CAR T cell expansion, persistence, and anti-tumor activityMiriam Y Kim, Reyka Jayasinghe, Jessica M Devenport, et al.
Cell Metabolism|August 3, 2022
CD24-Siglec axis is an innate immune checkpoint against metaflammation and metabolic disorderXu Wang, Mingyue Liu, Jifeng Zhang, et al.
Pediatric Dermatology|November 28, 2022
Defining patient-centered research priorities in pediatric dermatologyHolly Neale, Suz Schrandt, Becky M Abbott, et al.
Annals of the Rheumatic Diseases|February 9, 2020
Effect on efficacy and safety trial outcomes of also enrolling patients on ongoing glucocorticoid therapy in rheumatoid arthritis clinical trials of tocilizumab or adalimumab or methotrexate monotherapyMary Safy-Khan, Johannes W G Jacobs, Maria J H de Hair, et al.
Leukemia|October 5, 2023
An "off-the-shelf" CD2 universal CAR-T therapy for T-cell malignanciesJingyu Xiang, Jessica M Devenport, Alun J Carter, et al.
JAMA|July 13, 2018
Effect of Alteplase vs Aspirin on Functional Outcome for Patients With Acute Ischemic Stroke and Minor Nondisabling Neurologic Deficits: The PRISMS Randomized Clinical TrialPooja Khatri, Dawn O Kleindorfer, Thomas Devlin, et al.
Oral Oncology|December 12, 2018
The genomic landscape of UM-SCC oral cavity squamous cell carcinoma cell linesMegan L Ludwig, Aditi Kulkarni, Andrew C Birkeland, et al.
Antiviral Research|July 10, 2018
CD24 and Fc fusion protein protects SIVmac239-infected Chinese rhesus macaque against progression to AIDSRen-Rong Tian, Ming-Xu Zhang, Lin-Tao Zhang, et al.
Blood|August 30, 2023
A phase 2 trial of CD24Fc for prevention of graft-versus-host diseaseJohn Magenau, Samantha Jaglowski, Joseph Uberti, et al.
JCI Insight|June 17, 2021
Colorectal cancer cells utilize autophagy to maintain mitochondrial metabolism for cell proliferation under nutrient stressSamantha N Devenport, Rashi Singhal, Megan D Radyk, et al.
Pageof 20

Showing results (181-190 of 197) with videos related to

Sort By:
Pageof 20
Nature Communications|June 13, 2022
A long-acting interleukin-7, rhIL-7-hyFc, enhances CAR T cell expansion, persistence, and anti-tumor activityMiriam Y Kim, Reyka Jayasinghe, Jessica M Devenport, et al.
Cell Metabolism|August 3, 2022
CD24-Siglec axis is an innate immune checkpoint against metaflammation and metabolic disorderXu Wang, Mingyue Liu, Jifeng Zhang, et al.
Pediatric Dermatology|November 28, 2022
Defining patient-centered research priorities in pediatric dermatologyHolly Neale, Suz Schrandt, Becky M Abbott, et al.
Annals of the Rheumatic Diseases|February 9, 2020
Effect on efficacy and safety trial outcomes of also enrolling patients on ongoing glucocorticoid therapy in rheumatoid arthritis clinical trials of tocilizumab or adalimumab or methotrexate monotherapyMary Safy-Khan, Johannes W G Jacobs, Maria J H de Hair, et al.
Leukemia|October 5, 2023
An "off-the-shelf" CD2 universal CAR-T therapy for T-cell malignanciesJingyu Xiang, Jessica M Devenport, Alun J Carter, et al.
JAMA|July 13, 2018
Effect of Alteplase vs Aspirin on Functional Outcome for Patients With Acute Ischemic Stroke and Minor Nondisabling Neurologic Deficits: The PRISMS Randomized Clinical TrialPooja Khatri, Dawn O Kleindorfer, Thomas Devlin, et al.
Oral Oncology|December 12, 2018
The genomic landscape of UM-SCC oral cavity squamous cell carcinoma cell linesMegan L Ludwig, Aditi Kulkarni, Andrew C Birkeland, et al.
Antiviral Research|July 10, 2018
CD24 and Fc fusion protein protects SIVmac239-infected Chinese rhesus macaque against progression to AIDSRen-Rong Tian, Ming-Xu Zhang, Lin-Tao Zhang, et al.
Blood|August 30, 2023
A phase 2 trial of CD24Fc for prevention of graft-versus-host diseaseJohn Magenau, Samantha Jaglowski, Joseph Uberti, et al.
JCI Insight|June 17, 2021
Colorectal cancer cells utilize autophagy to maintain mitochondrial metabolism for cell proliferation under nutrient stressSamantha N Devenport, Rashi Singhal, Megan D Radyk, et al.
Pageof 20